"Health Insurance and Chronic Disease Control: Quasi-experimental Evidence from Hypertension in Rural China" is a chapter within the volume China's Healthcare System and Reform.
Karen Eggleston, Ruifang Zhang, Richard J. Zeckhauser
The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention.
The conference report from the workshop, Community Health Services and Primary Health Care Reform in China, held on June 18, 2015 at the Stanford Center at Peking University. The report is written...
The Institute for Public Policy at Hong Kong University of Science and Technology (HKUST) is soliciting papers for a workshop, “Reforming Public Hospitals in China: Emerging Models and Policy...
China’s recent initiatives to deepen health reform, control antimicrobial resistance, and strengthen primary health services are the topics of ongoing collaborative research by the Asia Health...
A long line of research has shown that women live longer than men, yet according to Karen Eggleston, director of the Asia Health Policy Program, and four other Stanford health researchers,...
A tremendous amount of radioactive products were discharged as a result of the accident at the Fukushima nuclear power plant in March 2011, which resulted in radioactive contamination of the plant...
Co-sponsored by the Center for South Asia, Stanford University Human life expectancy improved more in the last 50 years than in the preceding 5000 years.
Video and transcript from the presentation, "From Compression to Expansion of Morbidity: Upcoming Challenges for Healthcare and Long-term Care in China," on April 24, 2017, by Bei Lu, a postdoctoral fellow at the University of New South Wales,...
Audio and transcript from the Asia Health Policy Program seminar, "The Impact of Taiwan's National Health Insurance's 20-year Journey: How has the market responded and will respond?" on April 19, 2016, with Karen Eggleston, Jui-fen Rachel Lu and...
Audio and transcript from the Asia Health Policy Program seminar "Impact of China’s ‘Zero-markup Policy for Essential Drugs’ on Patients, County Hospital Revenue and Government Subsidy Levels" on April 5, 2016, with Yanfang Su.China implemented a...
